Publications by authors named "J M Schurr"
Article Synopsis
- * In a study of 150 patients, 59.3% achieved recovery or were able to receive a durable LVAD or a heart transplant, while 18.8% died within 90 days, indicating a significant success rate compared to mortality.
- * The device significantly improved hemodynamic measurements, such as reduced pulmonary artery diastolic pressure, suggesting better heart function, and even allowed for supporting patients with right ventricle dysfunction through careful monitoring of trends.
Introduction: A feared complication of an acute myocardial infarction (AMI) is cardiac arrest (CA). Even if return of spontaneous circulation is achieved, cardiogenic shock (CS) is common. Venoarterial extracorporeal membrane oxygenation (VA-ECMO) supports patients with CS and is often used in conjunction with an Impella device (2.
View Article and Find Full Text PDFBackground: The efficacy of extracorporeal membrane oxygenation (ECMO) as a bridge to left ventricular assist device (LVAD) remains unclear, and recipients of the more contemporary HeartMate 3 (HM3) LVAD are not well represented in previous studies. We therefore undertook a multicenter, retrospective study of this population.
Methods And Results: INTERMACS 1 LVAD recipients from five U.